Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Change in Account Payables (2018 - 2025)

TransMedics (TMDX) has 8 years of Change in Account Payables data on record, last reported at -$2.1 million in Q4 2025.

  • For Q4 2025, Change in Account Payables rose 34.23% year-over-year to -$2.1 million; the TTM value through Dec 2025 reached -$19000.0, up 98.64%, while the annual FY2025 figure was -$19000.0, 98.64% up from the prior year.
  • Change in Account Payables reached -$2.1 million in Q4 2025 per TMDX's latest filing, down from $2.5 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $3.9 million in Q4 2021 and bottomed at -$4.0 million in Q1 2022.
  • Average Change in Account Payables over 5 years is $368100.0, with a median of $352000.0 recorded in 2021.
  • Peak YoY movement for Change in Account Payables: tumbled 4793.9% in 2022, then skyrocketed 6919.44% in 2025.
  • A 5-year view of Change in Account Payables shows it stood at $3.9 million in 2021, then plummeted by 93.17% to $264000.0 in 2022, then soared by 57.58% to $416000.0 in 2023, then plummeted by 854.33% to -$3.1 million in 2024, then skyrocketed by 34.23% to -$2.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Account Payables were -$2.1 million in Q4 2025, $2.5 million in Q3 2025, and -$1.2 million in Q2 2025.